{"id":33275,"date":"2026-03-16T20:58:54","date_gmt":"2026-03-16T20:58:54","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/33275\/"},"modified":"2026-03-16T20:58:54","modified_gmt":"2026-03-16T20:58:54","slug":"roche-ramps-up-ai-computing-capacity-with-nvidia-chip-expansion","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/33275\/","title":{"rendered":"Roche ramps up AI computing capacity with Nvidia chip expansion"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">BERLIN, March 16 (Reuters) &#8211; Swiss drugmaker Roche said on Monday it had expanded its \u200c<a href=\"https:\/\/tech.yahoo.com\/ai\/\" data-ylk=\"slk:artificial intelligence;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;artificial intelligence&quot;}\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">artificial intelligence<\/a> computing capacity with more than \u200c2,100 <a href=\"https:\/\/finance.yahoo.com\/quote\/NVDA\/\" data-ylk=\"slk:Nvidia;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Nvidia&quot;}\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">Nvidia<\/a> chips to support drug and diagnostics development.<\/p>\n<p class=\"yf-1fy9kyt\">Roche said \u200bthe additional hardware would speed up work across its research and development operations, including modelling, data analysis and clinical trial processes.<\/p>\n<p class=\"yf-1fy9kyt\">The drugmaker said it had \u200cdeployed 2,176 Nvidia \u2060Blackwell graphics processing units (GPUs) across sites in the U.S. and Europe, giving it \u2060the largest GPU footprint in the industry.<\/p>\n<p class=\"yf-1fy9kyt\">The build-up, which began in 2023, is part of a \u200bwider collaboration \u200bwith Nvidia by \u200bRoche, which has been \u200cincreasing investment in AI tools as large pharmaceutical groups compete to cut development timelines and reduce costs.<\/p>\n<p class=\"yf-1fy9kyt\">&#8220;In healthcare, time is the most critical variable,&#8221; Chief Digital and Technology Officer Wafaa Mamilli said.<\/p>\n<p class=\"yf-1fy9kyt\">Drugmakers \u200chave announced a slew of \u200bdeals for tools to unleash \u200bthe promise of \u200bartificial intelligence, seen as the biggest \u200ctechnological breakthrough since the \u200binternet.<\/p>\n<p class=\"yf-1fy9kyt\">Agentic AI, which \u200brequires little human intervention, could increase clinical development productivity by about 35% to 45% \u200bover the next \u200cfive years, consultancy McKinsey said last year.<\/p>\n<p class=\"yf-1fy9kyt\">(Reporting \u200bby Maggie Fick, Writing by Friederike Heine; \u200bEditing by Alexander Smith)<\/p>\n","protected":false},"excerpt":{"rendered":"BERLIN, March 16 (Reuters) &#8211; Swiss drugmaker Roche said on Monday it had expanded its \u200cartificial intelligence computing&hellip;\n","protected":false},"author":2,"featured_media":33276,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[225,19741,6007,597,134],"class_list":{"0":"post-33275","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-artificial-intelligence","9":"tag-graphics-processing-units","10":"tag-nvidia","11":"tag-research-and-development","12":"tag-roche"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116240866620494854","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/33275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=33275"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/33275\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/33276"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=33275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=33275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=33275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}